300 related articles for article (PubMed ID: 33386071)
1. Potential natural inhibitors of xanthine oxidase and HMG-CoA reductase in cholesterol regulation: in silico analysis.
Marahatha R; Basnet S; Bhattarai BR; Budhathoki P; Aryal B; Adhikari B; Lamichhane G; Poudel DK; Parajuli N
BMC Complement Med Ther; 2021 Jan; 21(1):1. PubMed ID: 33386071
[TBL] [Abstract][Full Text] [Related]
2. In-silico Design and ADMET Studies of Natural Compounds as Inhibitors of Xanthine Oxidase (XO) Enzyme.
Malik N; Dhiman P; Khatkar A
Curr Drug Metab; 2017; 18(6):577-593. PubMed ID: 28302027
[TBL] [Abstract][Full Text] [Related]
3. Bioactivity guided fractionation and hypolipidemic property of a novel HMG-CoA reductase inhibitor from Ficus virens Ait.
Iqbal D; Khan MS; Khan MS; Ahmad S; Hussain MS; Ali M
Lipids Health Dis; 2015 Mar; 14():15. PubMed ID: 25884722
[TBL] [Abstract][Full Text] [Related]
4.
Mehmood A; Rehman AU; Ishaq M; Zhao L; Li J; Usman M; Zhao L; Rehman A; Zad OD; Wang C
Comb Chem High Throughput Screen; 2020; 23(9):917-930. PubMed ID: 32342806
[TBL] [Abstract][Full Text] [Related]
5. Exploration of natural product ingredients as inhibitors of human HMG-CoA reductase through structure-based virtual screening.
Lin SH; Huang KJ; Weng CF; Shiuan D
Drug Des Devel Ther; 2015; 9():3313-24. PubMed ID: 26170618
[TBL] [Abstract][Full Text] [Related]
6. Cleroda-4(18),13-dien-15,16-olide as novel xanthine oxidase inhibitors: An integrated in silico and in vitro study.
Nguyen HT; Vu TY; Dakal TC; Dhabhai B; Nguyen XHQ; Tatipamula VB
PLoS One; 2021; 16(6):e0253572. PubMed ID: 34191831
[TBL] [Abstract][Full Text] [Related]
7. Exploration of virtual candidates for human HMG-CoA reductase inhibitors using pharmacophore modeling and molecular dynamics simulations.
Son M; Baek A; Sakkiah S; Park C; John S; Lee KW
PLoS One; 2013; 8(12):e83496. PubMed ID: 24386216
[TBL] [Abstract][Full Text] [Related]
8. Xanthine oxidase inhibitory activity of nicotino/isonicotinohydrazides: A systematic approach from in vitro, in silico to in vivo studies.
Zafar H; Hayat M; Saied S; Khan M; Salar U; Malik R; Choudhary MI; Khan KM
Bioorg Med Chem; 2017 Apr; 25(8):2351-2371. PubMed ID: 28302506
[TBL] [Abstract][Full Text] [Related]
9. Insight into the mechanism of polyphenols on the activity of HMGR by molecular docking.
Islam B; Sharma C; Adem A; Aburawi E; Ojha S
Drug Des Devel Ther; 2015; 9():4943-51. PubMed ID: 26357462
[TBL] [Abstract][Full Text] [Related]
10. Exploring Leishmania donovani 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) as a potential drug target by biochemical, biophysical and inhibition studies.
Dinesh N; Pallerla DS; Kaur PK; Kishore Babu N; Singh S
Microb Pathog; 2014 Jan; 66():14-23. PubMed ID: 24239940
[TBL] [Abstract][Full Text] [Related]
11.
Gul A; Saad SM; Zafar H; Atia-Tul-Wahab ; Khan KM; Choudhary MI
Med Chem; 2023; 19(4):384-392. PubMed ID: 35726432
[TBL] [Abstract][Full Text] [Related]
12. Combining empirical knowledge, in silico molecular docking and ADMET profiling to identify therapeutic phytochemicals from Brucea antidysentrica for acute myeloid leukemia.
Bultum LE; Tolossa GB; Lee D
PLoS One; 2022; 17(7):e0270050. PubMed ID: 35895695
[TBL] [Abstract][Full Text] [Related]
13. Action mechanisms and interaction of two key xanthine oxidase inhibitors in galangal: Combination of in vitro and in silico molecular docking studies.
Ou R; Lin L; Zhao M; Xie Z
Int J Biol Macromol; 2020 Nov; 162():1526-1535. PubMed ID: 32777423
[TBL] [Abstract][Full Text] [Related]
14. An in-depth view of potential dual effect of thymol in inhibiting xanthine oxidase activity: Electrochemical measurements in combination with four way PARAFAC analysis and molecular docking insights.
Abbasi S; Gharaghani S; Benvidi A; Rezaeinasab M; Saboury AA
Int J Biol Macromol; 2018 Nov; 119():1298-1310. PubMed ID: 30096398
[TBL] [Abstract][Full Text] [Related]
15. Molecular Docking, Synthesis And Biological Evaluation Of Ergosteryl-Ferulate As A Hmg-Coa Reductase Inhibitor.
Aziz S; Elfahmi -; Soemardji AA; Sukrasno -
Pak J Pharm Sci; 2020 May; 33(3):997-1003. PubMed ID: 33191223
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
[TBL] [Abstract][Full Text] [Related]
17. Pharmacophore modeling, molecular docking and molecular dynamics studies on natural products database to discover novel skeleton as non-purine xanthine oxidase inhibitors.
Peng J; Li Y; Zhou Y; Zhang L; Liu X; Zuo Z
J Recept Signal Transduct Res; 2018 Jun; 38(3):246-255. PubMed ID: 29843539
[TBL] [Abstract][Full Text] [Related]
18. Computational Analysis and Synthesis of Syringic Acid Derivatives as Xanthine Oxidase Inhibitors.
Malik N; Khatkar A; Dhiman P
Med Chem; 2020; 16(5):643-653. PubMed ID: 31584375
[TBL] [Abstract][Full Text] [Related]
19. Study on the interaction mechanism between luteoloside and xanthine oxidase by multi-spectroscopic and molecular docking methods.
Chen J; Wang Y; Pan X; Cheng Y; Liu J; Cao X
J Mol Recognit; 2022 Dec; 35(12):e2985. PubMed ID: 35907782
[TBL] [Abstract][Full Text] [Related]
20. Xanthine oxidase inhibition study of isolated secondary metabolites from
Nguyen DK; Liu TW; Hsu SJ; Huynh QT; Thi Duong TL; Chu MH; Wang YH; Vo TH; Lee CK
Saudi Pharm J; 2024 Apr; 32(4):101980. PubMed ID: 38439949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
